Daniel M. Bloomfield

8.0k citations
97 papers · 5.3k indexed · 2 hit papers · h-index 39
Topics
Heart Failure Treatment and Management (35 papers)Cardiac electrophysiology and arrhythmias (23 papers)Cardiovascular Syncope and Autonomic Disorders (18 papers)

In The Last Decade

Daniel M. Bloomfield

96 papers receiving 5.2k citations

Hit Papers

Abelacimab for Prevention of Venous Thromboembolism20212026202220242021202550100150

Peers

Daniel M. Bloomfield
Comparison fields: 5 of 143
  • Cardiology and Cardiovascular Medicine 4.0k
  • Surgery 902
  • Pulmonary and Respiratory Medicine 776
  • Molecular Biology 541
  • Endocrinology, Diabetes and Metabolism 474
Replace Sunao Kojima with:
Sunao Kojima Japan
Claude R. Benedict United States
Louis J. Dell’Italia United States
Giuseppe Licata Italy
James M. Ritter United Kingdom
Michele Senni Italy
Savina Nodari Italy
Jalal K. Ghali United States
Luís Eduardo Paim Rohde Brazil
Kenneth Dickstein Norway
Daniel M. Bloomfield relative to Sunao Kojima Japan Sunao Kojima's profile →
Citations per field
00.5×3.5×
Sunao Kojima · 1×
Citations per year

Countries citing papers authored by Daniel M. Bloomfield

Since Specialization
Citations

This map shows the geographic impact of Daniel M. Bloomfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel M. Bloomfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel M. Bloomfield more than expected).

Fields of papers citing papers by Daniel M. Bloomfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel M. Bloomfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel M. Bloomfield. The network helps show where Daniel M. Bloomfield may publish in the future.

Co-authorship network of co-authors of Daniel M. Bloomfield

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel M. Bloomfield. A scholar is included among the top collaborators of Daniel M. Bloomfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel M. Bloomfield. Daniel M. Bloomfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillationbreakdown →
31
2 7
3 27
4 90
5 111
6 29
7 20
8 33
9 67
10 36
11 48
12 24
13 22
14 69
15 63
16 4
17 28
18 58
19 1
20 4

About Daniel M. Bloomfield

Daniel M. Bloomfield is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Nephrology, having authored 97 papers that have together received 5.3k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (35 papers), Cardiac electrophysiology and arrhythmias (23 papers) and Cardiovascular Syncope and Autonomic Disorders (18 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (4.0k citations), Nephrology (373 citations) and Complementary and alternative medicine (333 citations). Daniel M. Bloomfield has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Marco Metra, Gad Cotter, Piotr Ponikowski, Christopher M. O’Connor, John G.F. Cleland, Michael M. Givertz, Howard C. Dittrich, Beth A. Davison, Adriaan A. Voors and Rochelle L. Goldsmith. Their work appears in journals such as New England Journal of Medicine, The Lancet and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026